Activity in this selectionOct 20, 2026 · Jul 23, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- 0
1 roles undisclosed- New companies
- 2
First participation on record · 0 follow-on- Funding in participating rounds
- $21.6M
2 disclosed · full round size, not this investor’s share
Rounds
2 in this selectionRelaceRegulatory management software linking financial firms’ obligations to their operations and supporting evidence.
ParticipantQureightEnd-to-end imaging company for clinical trials with a focus on lung and heart disease.
Role not disclosed